Screening of newborns and high-risk group of children for inborn metabolic disorders using tandem mass spectrometry in South Korea: a three-year report
Hye-Ran Yoon(Seoul Medical Center), Si Houn Hahn(University of Washington), Junghan Song(Seoul National University Bundang Hospital), Son-Sang Seo, Son Moon Shin(Samsung (South Korea)), Won‐Ki Min(Ulsan College), Ho Joo Yoon(Seoul Medical Center), Seungwoo Kang(Soonchunhyang University Hospital Seoul), Jong‐Won Kim(Seoul National University Bundang Hospital), Dong Hwan Lee(Ulsan College), Dong Hee Cho(Samsung (South Korea)), Kyung Ryul Lee(Seoul Medical Center), Han‐Wook Yoo(CHA University Bundang Medical Center)
Cited by 81
Related Papers
Continued Beneficial Effects of Burosumab in Adults with X-Linked Hypophosphatemia: Results from a 24-Week Treatment Continuation Period After a 24-Week Double-Blind Placebo-Controlled Period
|Calcified Tissue International|2019|160
Time to treatment benefit for adult patients with Fabry disease receiving agalsidase β: data from the Fabry Registry
|Journal of Medical Genetics|2016|147
Importance of RNF213 polymorphism on clinical features and long-term outcome in moyamoya disease
|Journal of neurosurgery|2015|116
Identification of 15 loci influencing height in a Korean population
|Journal of Human Genetics|2009|114
PTPN11, SOS1, KRAS, and RAF1 gene analysis, and genotype–phenotype correlation in Korean patients with Noonan syndrome
|Journal of Human Genetics|2008|108